Adiponectin, diabetes, and coronary heart disease in older persons: Unraveling the paradox

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 9, 2008, Pages 3299-3301

  Sattar, Naveed ^a,b   Nelson, Scott M ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CYTOKINE; DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CARDIOVASCULAR RISK; DIABETES CONTROL; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG TARGETING; EDITORIAL; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; KNOCKOUT MOUSE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RANDOMIZATION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; WEIGHT CHANGE; WEIGHT REDUCTION;

EID: 51649124757     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1435     Document Type: Editorial

References (21)

1. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE 2001 The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953
2. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y 2002 Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731-737
3. Wannamethee SG, Lowe GD, Rumley A, Cherry L, Whincup PH, Sattar N 2007 Adipokines and risk of type 2 diabetes in older men. Diabetes Care 30:1200-1205
4. Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G, Funahashi T, Matsuzawa Y, Shimomura I, Dekker JM 2006 Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the Hoorn study. Diabetes Care 29:2498-2503
5. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF 2003 Adiponectin and protection against type 2 diabetes mellitus. Lancet 361:226-228
6. Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA 2004 Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 89:200-206
7. Nishimura M, Izumiya Y, Higuchi A, Shibata R, Qiu J, Kudo C, Shin HK, Moskowitz MA, Ouchi N 2008 Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 117:216-223
8. Wu X, Mahadev K, Fuchsel L, Ouedraogo R, Xu SQ, Goldstein BJ 2007 Adiponectin suppresses IκB kinase activation induced by tumor necrosis factor-α or high glucose in endothelial cells: role of cAMP and AMP kinase signaling. Am J Physiol Endocrinol Metab 293:E1836-E1844
9. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J, Takata M, Eto K, Terauchi Y, Komeda K, Tsunoda M, Murakami K, Ohnishi Y, Naitoh T, Yamamura K, Ueyama Y, Froguel P, Kimura S, Nagai R, Kadowaki T 2003 Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278:2461-2468
10. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB 2004 Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291:1730-1737
11. Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, Danesh J, Whincup PH 2006 Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 114:623-629
12. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P 2005 Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112:1756-1762
13. Pilz S, Mangge H, Wellnitz B, Seelhorst U, Winkelmann BR, Tiran B, Boehm BO, Marz W 2006 Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab 91:4277-4286
14. Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, Pereira AA, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ 2006 Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 17:2599-2606
15. Laughlin GA, Barrett-Connor E, May S, Langenberg C 2007 Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol 165:164-174
16. Wannamethee SG, Whincup PH, Lennon L, Sattar N 2007 Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med 167:1510-1517
17. McEntegart MB, Awede B, Petrie MC, Sattar N, Dunn FG, MacFarlane NG, McMurray JJ 2007 Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 28:829-835
18. Dekker JM, Funahashi T, Nijpels G, Pilz S, Stehouwer CD, Snijder MB, Bouter LM, Matsuzawa Y, Shimomura I, Heine RJ 2008 Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 93:1489-1496
19. Sattar N, Wannamethee SG, Forouhi NG 2008 Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities? Diabetologia 51:926-940
20. Sattar N, Watt P, Cherry L, Ebrahim S, Davey Smith G, Lawlor DA 2008 High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study. J Clin Endocrinol Metab 93:1846-1849
21. Casas JP, Shah T, Cooper J, Hawe E, McMahon AD, Gaffney D, Packard CJ, O'Reilly DS, Juhan-Vague I, Yudkin JS, Tremoli E, Margaglione M, Di Minno G, Hamsten A, Kooistra T, Stephens JW, Hurel SJ, Livingstone S, Colhoun HM, Miller GJ, Bautista LE, Meade T, Sattar N, Humphries SE, Hingorani AD 2006 Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol 35:922-931